⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9064012 | 1.00 | — | — | |
| SCHEMBL2402171 | 1.00 | — | — | |
| SCHEMBL8818036 | 0.88 | — | — | |
| SCHEMBL3514875 | 0.81 | — | — | |
| SCHEMBL3514870 | 0.81 | — | — | |
| SCHEMBL6898990 | 0.78 | THRB (0.36) | — | |
| SCHEMBL723671 | 0.75 | TET2 (0.33) | — | |
| SCHEMBL891799 | 0.75 | PKM (0.30) | — | |
| SCHEMBL8006729 | 0.72 | PKM (0.33) | — | |
| SCHEMBL270058 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| CN-110415865-B | Optically consistent transparent conductive film and preparation method thereof | 北京华纳高科科技有限公司 | 2020-07-03 | — | — | CN | disclosed |
| US-8012658-B2 | binder resin including a polyester resin and a vinyl resin which the monomer having an alkyloxysilyl group, a wax and a colors; good fixability, durability, noncracking during high speed recording without causing the offset problem | RICOH COMPANY LIMITED (JP) | 2011-09-06 | — | — | US | disclosed |
| US-7829254-B2 | Non-magnetic toner, image forming apparatus and process cartridge | RICOH COMPANY, LTD. (JP) | 2010-11-09 | — | — | US | disclosed |
| US-20080220357-A1 | TONER FOR DEVELOPING ELECTROSTATIC IMAGE, AND IMAGE FORMING APPARATUS AND PROCESS CARTRIDGE USING THE TONER | RICOH COMPANY LIMITED (JP) | 2008-09-11 | — | — | US | disclosed |
| US-20070218388-A1 | NON-MAGNETIC TONER, IMAGE FORMING APPARATUS AND PROCESS CARTRIDGE | RICOH COMPANY, LTD. (JP) | 2007-09-20 | — | — | US | disclosed |
| EP-1303258-B1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2006-10-11 | — | — | EP | disclosed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | disclosed |
| EP-0524557-B1 | Ocular lens material | MENICON CO LTD (JP) | 1996-01-17 | — | — | EP | disclosed |
| US-5250583-A | Polymer of fluoroalkyl silicon-containing alkyl fumarate, N-vinyllactam, acrylic or methacrylic acid, crosslinkable monomer | MENICON CO., LTD. (JP) | 1993-10-05 | — | — | US | disclosed |
| EP-0524557-A2 | Ocular lens material | Menicon Co., Ltd. (JP) | 1993-01-27 | — | — | EP | disclosed |